Caixin China Biz Roundup: Experimental Covid-19 Drug Remdesivir Delivers Conflicting Verdicts

In today’s episode: initial results from a U.S. study suggest the drug might be effective, yet results from a Chinese trial point in the other direction; Chinese academics find themselves at the center of a fresh plagiarism scandal; and the latest figures for the nation’s manufacturing sector